Focused Wealth Management’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Focused Wealth Management’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15	Closed	-$112	–	1015
2023 Q4	$112	Hold	15	–	–	﹤0.01%	969
2023 Q3	$150	Hold	15	–	–	﹤0.01%	972
2023 Q2	$155	Hold	15	–	–	﹤0.01%	1009
2023 Q1	$157	Hold	15	–	–	﹤0.01%	989
2022 Q4	$191	Hold	15	–	–	﹤0.01%	1020
2022 Q3	$0	Hold	15	–	–	﹤0.01%	1077
2022 Q2	$0	Hold	15	–	–	﹤0.01%	1103
2022 Q1	$1K	Sell	15 -5	-25%	-$180	﹤0.01%	953
2021 Q4	$1K	Buy	20 +10	+100%	+$527	﹤0.01%	947
2021 Q3	$1K	Hold	10	–	–	﹤0.01%	958
2021 Q2	$1K	Hold	10	–	–	﹤0.01%	900
2021 Q1	$1K	Sell	10 -10	-50%	-$1.11K	﹤0.01%	884
2020 Q4	$1K	Buy	+20	New	+$740	﹤0.01%	793

Other funds holding CSCI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Truvestments Capital Sarasota, Florida $673M AUM 55.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Focused Wealth Management's CSCI Position: Q1 2024 in Review

Focused Wealth Management sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q1 2024, closing a stake of 15 shares — an estimated $112 sold.

Focused Wealth Management first reported a position in CSCI in Q4 2020 and held it in 13 quarters. The position peaked at $1K in Q1 2022. 10 funds tracked by Wall St. Rank hold CSCI as of Q1 2024.

Focused Wealth Management reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Focused Wealth Management sold 15 COSCIENS Biopharma Inc. Common Stock shares in Q1 2024, an estimated $112.
Focused Wealth Management first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2020 and held it in 13 quarters.
Focused Wealth Management's COSCIENS Biopharma Inc. Common Stock position peaked at $1K in Q1 2022.
10 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.